Primary sarcoma of the liver: A nationwide analysis of a rare mesenchymal tumor.
Nicole FinneyTu TranBima J HasjimJames JakowatzElaine ChiaoOliver S EngRonald WolfZeljika JutricMaki YamamotoThuy B TranPublished in: Journal of surgical oncology (2023)
Surgery remains the mainstay of treatment for this rare malignancy but is performed in less than one-third of patients. Angiosarcoma histology is associated with worse overall survival, while surgical resection remains the strongest predictor of improved overall survival.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- stem cells
- minimally invasive
- peritoneal dialysis
- bone marrow
- free survival
- prognostic factors
- coronary artery bypass
- patient reported outcomes
- cross sectional
- replacement therapy
- patient reported
- atrial fibrillation
- surgical site infection
- combination therapy